Canopy Growth (CGC) EBT Margin (2019 - 2025)

Canopy Growth (CGC) reported EBT Margin of 50.3% for Q4 2025, up 8048.0% on a YoY basis from 0.62% in Q4 2024, and down 604.01% sequentially from 7.14% in Q3 2025.

Canopy Growth (CGC) EBT Margin (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of EBT Margin data on file, last reported at 50.3% in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 8048.0% year-over-year to 50.3%; the trailing twelve-month figure through Dec 2025 stood at 59.46% (up 10846.0% YoY), and the FY2026 full-year result was 422.48%, down 127021.0% from the prior year.
  • EBT Margin slipped to 50.3% in Q4 2025, from 7.14% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 288.42% in Q2 2021 to a low of 1759.55% in Q2 2022.
  • A 5-year average of 212.6% and a median of 153.65% in 2024 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin surged 478671 bps in 2021 and plunged 204797 bps in 2022, its largest moves.
  • Tracing CGC's EBT Margin over 5 years: stood at 74.62% in 2021, then slumped by 260 bps to 268.92% in 2022, then retreated by 4 bps to 280.52% in 2023, then surged by 53 bps to 130.77% in 2024, then soared by 62 bps to 50.3% in 2025.
  • Business Quant data shows CGC's EBT Margin at 50.3% in Q4 2025, 7.14% in Q3 2025, and 61.79% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -50.30%
Sep 30, 2025 -7.14%
Jun 30, 2025 -61.79%
Dec 31, 2024 -130.77%
Sep 30, 2024 -177.67%
Jun 30, 2024 -153.65%
Mar 31, 2024 -209.19%
Dec 31, 2023 -280.52%
Sep 30, 2023 -182.09%
Jun 30, 2023 -11.21%
Mar 31, 2023 -519.95%
Dec 31, 2022 -268.92%
Sep 30, 2022 -214.06%
Jun 30, 2022 -1,759.55%
Mar 31, 2022 151.59%
Dec 31, 2021 -74.62%
Sep 30, 2021 -14.87%
Jun 30, 2021 288.42%
Mar 31, 2021 -363.11%
Dec 31, 2020 -4,861.33%